Filing search / Wave Life Sciences Ltd. / "Litigation" / Page 3

8-K

EX-99.1

5g535

18 Oct 21

Entry into a Material Definitive Agreement

5:06pm

8-K

EX-99.2

ycu8xbrfok242rpv3

28 Sep 21

Regulation FD Disclosure

4:11pm

8-K

EX-99.1

i6dbj6

2 Jun 21

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency

5:24pm

8-K

EX-99.1

f9da3w092wnb7

23 Sep 20

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

4:31pm

8-K

EX-1.1

tepe6 ut6o4

23 Sep 20

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

4:31pm

8-K

EX-99.1

xoakm5 nki1jd

22 Sep 20

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares

4:17pm

POS AM

80pjc1h55a 1c0rm99q

2 Mar 20

Prospectus update (post-effective amendment)

8:15am

POSASR

v5neph00j10

2 Mar 20

Automatic shelf registration (post-effective amendment)

6:28am

POSASR

EX-5.1

vk4bp 55p

2 Mar 20

Automatic shelf registration (post-effective amendment)

6:28am

8-K

EX-99.1

cvi9v0

5 Sep 19

Wave Life Sciences Expands Board of Directors with Three New Appointments

7:35am

S-3ASR

rw4x8 5288

10 May 19

Automatic shelf registration

4:20pm